Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 25, 2020
View Archived Issues
Dosing completed in phase I study of ML-004 as therapy for social deficit in ASD
Read More
Making exceptional responders unexceptional
Read More
Twist reports preclinical data on antibodies against S1 protein in SARS-CoV-2
Read More
FDA approves Xofluza for post-exposure prophylaxis of influenza
Read More
Capricor initiates dosing in phase II study of CAP-1002 in severe COVID-19
Read More
Genmab halts development of enapotamab vedotin
Read More
CTA for first-in-human study of FS-222 receives clearance in Spain
Read More
Cure Biopharma patents gemcitabine prodrugs for cancer
Read More
Incyte discloses new CDK2/cyclin E inhibitors
Read More
Snap Bio presents new Pim-1 and/or Pim-3 kinase inhibitors
Read More
Merck & Co. describes new nicotinic alpha7 receptor PAMs
Read More
Humabs BioMed divulges antibodies targeting influenza A HA protein
Read More
Tremfya approved in E.U. for active psoriatic arthritis
Read More
Final phase I/II data for PLX-9486 plus sunitinib in GIST
Read More
First-in-human data presented for Plasmodium falciparum transmission-blocking MAb
Read More
shMKK4-224: an MKK4 inhibitor for liver regeneration
Read More
Initial first-in-human data on BMS-986218 support further evaluation
Read More
Antimicrobial polymers AMP up fight against MDR bacteria
Read More
Phase III interim data reported on Sputnik V COVID-19 vaccine candidate
Read More
Treating Zika virus in a pregnant nonhuman primate model
Read More
Topline phase IIa data on vibegron in IBS show primary endpoint not met
Read More
FDA approves Oxlumo for primary hyperoxaluria type 1
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe